Cooley M&A

JANUARY 22, 2020

A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in the pharmaceutical, medical and biotech industry reaching $234.2 2019 was a banner year for billion-dollar life sciences M&A transactions.

M&A 40

M&A Pharmaceutical Acquisitions Capital 40

Peak Frameworks

SEPTEMBER 19, 2023

company to hit a $1 trillion valuation , it directly benefited shareholders. This deep involvement requires them to understand: Shareholder Interests: To gauge the return on investment and determine the valuation of potential deals. Shareholders: are primarily concerned about financial returns.

Corporation 52

Corporation Private Equity Mergers and Acquisitions Corporate Finance 52

Cooley M&A

JANUARY 25, 2023

Amid depressed valuations, biotechnology companies also saw an increasing number of demands from activist investors that in certain cases led to more deal activity. For example, the sale of Horizon Therapeutics to Amgen for approximately $28 billion was the third-largest all-cash transaction in the pharmaceutical sector in history.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

InvestmentBank.com

SEPTEMBER 18, 2019

Now Amazon truly does have more than a foot in the door to the pharmaceutical market. It is logical to think that Walmart will start making DTC pharmaceuticals a part of its push away from shopping in brick and mortar to have pick-up stations and home delivery. What was the premium above the 2016 valuation? EBITDA multiple.

Food 52

Food Valuation Acquisitions M&A 52

How2Exit

MARCH 31, 2024

This episode serves as a deep dive into Patrick's journey from a young accounting graduate to a M&A powerhouse, navigating transactions in industries as varied as HVAC and pharmaceuticals. rn Key Takeaways: rn rn rn Business valuation is often industry-specific, and the market sets the price based on comparable sales in the recent past.

Business 130

Business Mergers and Acquisitions Securities M&A 130

Software Equity Group

JANUARY 22, 2024

Urgency Drives Healthy M&A Valuations Beyond the standard financial metrics that typically create valuations in any industry, the healthcare sector has several distinctive elements that significantly contribute to its valuation dynamics. Click here to fill out our assessment form.

Healthcare 52

Healthcare M&A Valuation Medical 52

Software Equity Group

JANUARY 22, 2024

Urgency Drives Healthy M&A Valuations Beyond the standard financial metrics that typically create valuations in any industry, the healthcare sector has several distinctive elements that significantly contribute to its valuation dynamics. Click here to fill out our assessment form.

Healthcare 52

Healthcare M&A Valuation Medical 52

Mergers and Inquisitions

NOVEMBER 1, 2023

Mispriced Companies and Assets – Some mature healthcare firms trade at low valuation multiples , often because the market misunderstands their contracts, revenue, or track record. Areas like healthcare services and medical devices are fairly generalist and follow standard accounting and valuation. For example, in the U.S.,

Private Equity 59

Private Equity Healthcare Equities Middle Market 59

M&A Leadership Council

JUNE 12, 2023

Second, impact to deal valuation or terms. Concerning valuation or deal terms, the earlier you detect a breach or a strong possibility of a breach, the better so you can help corporate development decide how best to address the issues. MH: We often talk about due diligence findings in three successive phases.

IT 52

IT M&A Securities Insurance 52

Cooley M&A

OCTOBER 29, 2018

In April 2017, Fresenius agreed to acquire Akorn, a US-based, Nasdaq-listed specialty manufacturer and marketer of generic prescription and over-the-counter pharmaceutical products, for $35 per share or approximately $4.75 The Merger Agreement.

Mergers and Acquisitions 52

Mergers and Acquisitions Mergers Business Pharmaceutical 52

Devensoft

MAY 25, 2023

For instance, a pharmaceutical company may acquire a smaller biotech firm to gain access to its research and development pipeline.  For example, a tech company may merge with a marketing firm to leverage the latter’s customer data and advertising capabilities.

Corporation 52

Corporation Mergers Mergers and Acquisitions Acquisitions 52

M&A Leadership Council

SEPTEMBER 9, 2021

Second, impact to deal valuation or terms. Concerning valuation or deal terms, the earlier you detect a breach or a strong possibility of a breach, the better so you can help corporate development decide how best to address the issues. MH: We often talk about due diligence findings in three successive phases.

IT 52

IT M&A Securities Insurance 52

Cooley M&A

FEBRUARY 8, 2018

Second, the FTC continues to aggressively target pharmaceutical companies in connection with mergers and acquisitions. The outcome of the AT&T/Time Warner merger challenge, now set for trial starting March 19, may therefore significantly impact vertical merger antitrust law. Use of Earn-Outs in Life Sciences Deals.

M&A 52

M&A Mergers and Acquisitions Mergers Negotiation 52

Growth Business

MAY 31, 2023

Members look to invest in companies with a pre-money valuation of £1m and £5m looking to raise between £250,000 and £5m. Although the network is open to members of any gender, the requirements are that a female has at least 20 per cent of founder equity. Successful founders typically attract £70,000 to £350,000.

Investment 73

Investment Investors Funds Healthcare 73

Cooley M&A

JANUARY 30, 2024

These dynamics help explain why, despite significant sector-wide declines in public tech and life sciences company valuations from 2021 peaks, we have yet to mark a dramatic increase in activism campaigns relative to historical levels: for many would-be targets, there was no clear “fix” available.

Private Equity 52

Private Equity M&A Investors Capital 52

Cooley M&A

JANUARY 22, 2021

The second half of the year witnessed a rebound spurred by several multibillion-dollar deals, including Gilead’s acquisition of Immunomedics for nearly $21 billion and AstraZeneca’s proposed acquisition of Alexion Pharmaceuticals for $39 billion. While deal value was down for the year, deal volume was relatively stable (down only 2.0%

M&A 40

M&A Mergers and Acquisitions Collaboration Mergers 40

Cooley M&A

JANUARY 20, 2022

1] Major all-cash acquisitions have followed, such as Arena Pharmaceutical’s agreement to sell to Pfizer for $6.7 Midsize pharmaceutical buyers pursuing opportunistic acquisition strategies, with robust capital markets and high valuations having limited the pool of attractive assets available in recent years.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Cooley M&A

JULY 10, 2017

However, where there are too many unaccredited investors, parties may be unwilling or unable to pay the present cash value of the future earn-outs to the unaccredited investors (which would require a valuation of the future earn-outs). acquisitions of pharmaceutical products with clinical, regulatory and/or net sales milestones).

Securities 52

Securities IT Investors M&A 52

Cooley M&A

FEBRUARY 15, 2017

After some highly anticipated IPOs in the first half of 2017, we expect the reopening of capital markets in the latter half of the year to provide more stabilized valuations for companies, which should lead to more normalcy in M&A and strategic combinations.

M&A 40

M&A IPO Pharmaceutical Valuation 40

InvestmentBank.com

MAY 18, 2021

The healthcare industry is formed of numerous subsectors including pharmaceutical services, diagnostics, medical technologies, and managed healthcare. Payor services and pharmaceutical services have generated the most return throughout 2016 and in 1Q 2017. The pharmaceutical industry is valued highly given the performance of buyouts.

Healthcare 40

Healthcare M&A Valuation Hospitality 40